Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert Opinion.

Autor: Soares A; Oncology and Hematology Center of Hospital Albert Einstein, Hospital Albert Einstein, Sao Paulo, Brazil. Electronic address: dr.andrey@uol.com.br., Bourlon MT; Hemato-Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Wong A; Sr Consultant, Department of Haematology Oncology National University Cancer Institute, Singapore., Joshi A; Professor, Medical Oncology, Tata Memorial Centre, HBNI, Mumbai, India., Jardim D; Oncology Department, Oncoclínicas Institute, São Paulo, Brazil., Korbenfeld E; Head of GU Tumors Unit, GU Tumors Unit, Hospital Británico de Buenos Aires, Buenos Aires, Argentina., Karak FE; Hematology and Medical Oncology Service, University Medical Center Hôtel-Dieu De France Hospital, Faculty of Medicine, Saint Joseph University of Beirut, Lebanon., Orlandi F; Medical Director, Orlandi Oncología Providencia, Chile., Sze H; Specialist in Clinical Oncology, Heal Oncology Centre, Hong Kong, China., Ansari J; Chief of Medical Oncology, Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates., Zarba J; Medical Oncologist, Centro Médico San Roque, Tucumán, Argentina., Mansour MA; Adult Medical Oncology, Princess Noorah Oncology Center, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia., Manneh R; edical Oncology, Sociedad de Oncología y Hematología del Cesar, Valledupar, Colombia., Thirumulai R; Senior Consultant, Medical Oncology, Apollo Specialty Hospital, Chennai, India., Tsai YC; Clinical Assistant Professor, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Morsi WA; GU & BSM Sr. Director Scientific Expert, Oncology Medical Affairs, Emerging Markets, Pfizer Ltd., Dubai, United Arab Emirates., Powles T; Director of Barts Cancer Center, Professor of Urology Cancer, Barts Cancer Institute, London, United Kingdom.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Apr; Vol. 22 (2), pp. 467-475. Date of Electronic Publication: 2024 Jan 03.